{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:13:17Z","timestamp":1777378397264,"version":"3.51.4"},"reference-count":55,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["AIDS Research and Human Retroviruses"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:p>In the past few years, the transdisciplinary field of HIV prevention has reached several milestones. Topically applied tenofovir gel provided significant protection from sexual transmission of HIV in a large-scale clinical trial and oral Truvada (emtricitabine\/tenofovir disoproxil fumarate) was recently approved for preexposure prophylaxis (PrEP) following two successful clinical trials in men and women. These achievements are tempered by the disappointing results of other clinical trials, which highlight the complexities of prevention research. In this perspective, we discuss scientific and developmental gaps for topical chemoprophylaxis of the sexual transmission of HIV, which depends on the complex interactions between the pharmacokinetics and pharmacodynamics of drugs, formulation and delivery systems, anatomic site of transmission, and host mucosal immune defenses. Despite the considerable time and resources devoted to unraveling the initial steps in sexual transmission of HIV, current knowledge is based on animal models and human explanted tissue, which may not fully recapitulate what happens clinically. Understanding these events, including the role that sex hormones, semen, and mucosal secretions play in transmission, and the interplay between innate immunity, the mucosal environment, and drug efficacy is paramount. This drives some of the most pressing questions in the field.<\/jats:p>","DOI":"10.1089\/aid.2012.0277","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T23:39:59Z","timestamp":1347406799000},"page":"1373-1378","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["A Perspective on Progress and Gaps in HIV Prevention Science"],"prefix":"10.1177","volume":"28","author":[{"given":"Patrick F.","family":"Kiser","sequence":"first","affiliation":[{"name":"University of Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro M.M.","family":"Mesquita","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy C.","family":"Herold","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,11,1]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108524"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/487283a"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1193748"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70247-X"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.2174\/157016212799304643"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-2-27"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/522606"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008781"},{"issue":"3","key":"e_1_3_3_10_2","first-page":"S174","article-title":"Preclinical assessment of the proinflammatory potential of microbicide candidates","volume":"37","author":"Doncel GF","year":"2004","unstructured":"Doncel GF, , Chandra N, , Fichorova RN. Preclinical assessment of the proinflammatory potential of microbicide candidates. J Acquir Immune Defic Syndr, 2004; 37,Suppl 3:S174\u2013180.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/322047"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/600867"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027675"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1463"},{"key":"e_1_3_3_15_2","unstructured":"Network MTN. Microbicide Trials Network Statement on Decision to Discontinue Use of Tenofovir Gel in VOICE a Major HIV Prevention Study in Women. 2012[cited 2012 September 4th]http:\/\/www.mtnstopshiv.org\/sites\/default\/files\/attachments\/MTNStatementNov17DSMB_final.pdf."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks173"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks097"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00399-12"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2008.0184"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2006.06.026"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02422-10"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003162"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711813105"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05721-11"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(07)56008-4"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.2174\/157016206777709492"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.456"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0902239106"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-008-9765-2"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01339-10"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f736f4"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2010.32"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2010.00933.x"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328321b778"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-009-0004-1"},{"key":"e_1_3_3_36_2","article-title":"Latest understanding of HIV sexual transmission","author":"Hope TJ","year":"2008","unstructured":"Hope TJ. Latest understanding of HIV sexual transmission. Microbicides, 2008 February 25, 2008 Delhi, India2008.","journal-title":"Microbicides"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature08757"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-080709-124959"},{"key":"e_1_3_3_39_2","volume-title":"Protection from HIV: Targeted Intervention Strategies","author":"Mesquita P","year":"2011","unstructured":"Mesquita P, , Torres N, , Segarra T et al. Intravaginal ring formulation of tenofovir disoproxil fumarate (TDF) facilitates rapid bioavailability of drug, protects cervical explants from HSV-2 infection. Protection from HIV: Targeted Intervention Strategies, Keystone Symposia, March 20\u201325. British Columbia, Canada, 2011."},{"key":"e_1_3_3_40_2","volume-title":"19th Conference on Retroviruses and Opportunistic Infections","author":"Mesquita P","year":"2012","unstructured":"Mesquita P, , Rastogi R, , Johnson T et al. Intravaginal ring delivery of the pyrimidinedione IQP-0528 results in protective concentrations in vaginal biopsies of pigtailed macaques, novel models to assess pharmacokinetics\/pharmacodynamics. 19th Conference on Retroviruses and Opportunistic Infections, March 5\u20138, Seattle, WA, 2012."},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200005"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gam028"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102736"},{"issue":"1","key":"e_1_3_3_44_2","first-page":"62","article-title":"State of the art in intravaginal ring technology for topical prophylaxis of HIV infection","volume":"14","author":"Kiser PF","year":"2012","unstructured":"Kiser PF, , Johnson TJ, , Clark JT. State of the art in intravaginal ring technology for topical prophylaxis of HIV infection. AIDS Rev, 2012; 14,1:62\u201377.","journal-title":"AIDS Rev"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis465"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318220ebd3"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040415"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000416"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001251"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2010.0129"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-009-0072-9"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003174"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.3.612"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)99923-0"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00311-11"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-100002341"}],"container-title":["AIDS Research and Human Retroviruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/aid.2012.0277","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/aid.2012.0277","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/aid.2012.0277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:10:56Z","timestamp":1777367456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/aid.2012.0277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1089\/aid.2012.0277"],"URL":"https:\/\/doi.org\/10.1089\/aid.2012.0277","relation":{},"ISSN":["0889-2229","1931-8405"],"issn-type":[{"value":"0889-2229","type":"print"},{"value":"1931-8405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}